Terumo Corp. (TYO:4543) said today its Vascutek subsidiary and Bolton Medical have merged together to form a new company, Terumo Aortic. The newly combined company is expected to have a revenue of more than $200 million, and will employ more than 1,100 individuals worldwide, Tokyo-based Terumo said. Terumo Aortic will look to accelerate its position in treating aortic […]
Bolton Medical said today it won CE Mark approval in the European Union for its Treo abdominal stent-graft for treating abdominal aortic aneurysms. The endovascular aneurysm repair device is designed as a modular 3-piece system with dual proximal fixation and a unique proximal clasping mechanism, the Sunrise, Fla.-based company said. “We believe that in EVAR, […]
Bolton Medical launched phase II of its U.S. clinical trial for its Treovance abdominal stent graft system and corresponding Navitel delivery system.
The Treovance stent graft is designed to be adaptable and flexible in order to accommodate a wide range of anatomies. The Navitel delivery system includes a proximal clasping system for precise delivery.
The phase II study will treat 150 patients with infrarenal aortic aneurysms, enrolled at 30 institutions located throughout the U.S., according to the press release.
Florida-based stent maker Bolton Medical won FDA clearance for its thoracic-specific stent-graft system, the company announced today.
Bolton’s Relay thoracic stent-graft device and delivery system is designed specifically for minimally invasive treatment of thoracic aortic aneurysms and penetrating atherosclerotic ulcers, and it comes in a range of sizes, according to a press release.